◀ Back to FGF2
FGF2 — SDC1
Pathways - manually collected, often from reviews:
Protein-Protein interactions - manually collected from original source literature:
Studies that report less than 10 interactions are marked with *
Text-mined interactions from Literome
Bodo et al., Eur J Cell Biol 1999
(Craniofacial Dysostosis) :
A regulatory
role of
fibroblast growth factor in the expression of decorin, biglycan, betaglycan and
syndecan in osteoblasts from patients with Crouzon 's syndrome
Jaakkola et al., Prog Nucleic Acid Res Mol Biol 1999
:
In fibroblasts
syndecan-1 is
induced by
FGF-2 and in keratinocytes by epidermal growth factor (EGF) and keratinocyte growth factor (KGF)
Pursiheimo et al., Proc Natl Acad Sci U S A 2000
:
The PKA-specific inhibitor H-89 ( N- [ 2- ( p-bromocinnamylamino ) ethyl ] -5-isoquinolinesulfonamide ) blocked the
FGF-2 induced activation of FiRE, the transcription of the
syndecan-1 gene, and cell proliferation ... Also, expression of a dominant negative form of PKA inhibited the
FGF-2 induced FiRE activation and the transcription of the
syndecan-1 gene
Jaakkola et al., Biochem Biophys Res Commun 2000
:
Proximal promoter independent
activation of
syndecan-1 gene by
FGF-2 might be required during development when syndecan-1 proximal promoter needs to be largely attenuated but simultaneous transient and rapid FGF-2 induced transcription is required
Worapamorn et al., J Cell Physiol 2001
:
Syndecan-1 mRNA levels increased in
response to serum,
bFGF and PDGF-BB, but decreased in response to TGF-beta1, IL-1beta and IFN-gamma
Qiao et al., J Biol Chem 2003
(Glioma...) :
In contrast, overexpression of
syndecan-1 had no effect on growth or
FGF2 sensitivity
Velleman et al., Poult Sci 2007
:
This result indicates that
FGF2 responsiveness was not
affected by the overexpression of
syndecan-1 , syndecan-4, and glypican-1 during differentiation ... This result indicates that
FGF2 responsiveness was not
affected by the overexpression of syndecan-1,
syndecan-4 , and glypican-1 during differentiation
Shimabukuro et al., Matrix Biol 2008
:
However, reverse transcription-polymerase chain reaction data ( RT-PCR ) revealed that
FGF-2 marginally
reduced the gene expression of
syndecan-1 , -2, and -4, and did not alter the level of syndecan-3 mRNA
Ruohola et al., Endocrinology 1995
(Mammary Neoplasms, Experimental) :
FGF-2 also
down-regulated the expression of
syndecan-1 , a heparan sulfate proteoglycan that binds FGF with low affinity
LarraĆn et al., J Biol Chem 1997
:
Basic fibroblast growth factor and transforming growth factor type beta, which are inhibitors of myogenesis,
had little effect on
syndecan-1 expression
Filla et al., J Cell Physiol 1998
(Burkitt Lymphoma) :
The cell surface proteoglycan
syndecan-1 mediates
fibroblast growth factor-2 binding and activity